Vor Biopharma Inc. (NYSE:VOR) Given Consensus Rating of “Buy” by Analysts
Vor Biopharma Inc. (NYSE:VOR – Get Free Report) has received an average rating of “Buy” from the seven analysts that are ...
Vor Biopharma Strengthens Board with New Appointment
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Yahoo Finance27d
Vor Bio Announces $55.6 Million Private Placement
CAMBRIDGE, Mass., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it has entered into a securities purchase ...
Seeking Alpha26d
Vor Bio announces $55.6M private placement, shares soar
Vor Bio (NASDAQ:VOR) shares soared more than 20% in Friday pre-market trading, after it said that it has entered into a securities purchase agreement for a private investment in public equity ...
Nasdaq14d
Vor Bio Appoints Erez Kalir to Board of Directors Amid New Financing Round
The statement from Mr. Kalir expressing strong belief in Vor Bio's potential to revolutionize blood cancer treatment underscores the company's promising position in the biotech market. The ...
TMCnet14d
Vor Bio Appoints Life Sciences and Technology Investor and Entrepreneur, Mr. Erez Kalir to its Board of Directors
Mr. Kalir brings a wealth of experience as an investor, entrepreneur, and thought leader with a deep focus on life sciences and technology. Currently the Managing Member of Martial Eagle Fund and a ...